AMNEAL PHARMACEUTICALS, INC. Accrued Royalties, Current
AMNEAL PHARMACEUTICALS, INC. (AMRX) had Accrued Royalties, Current of $27.49 million as of 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Notes › Accrued Liabilities, Current
us-gaap:AccruedRoyaltiesCurrent · last filed 2025-11-06
- 2025-09-30: Accrued Royalties, Current $27.49M.
- 2025-06-30: Accrued Royalties, Current $23.85M.
- 2025-03-31: Accrued Royalties, Current $24.51M.
- 2024-12-31: Accrued Royalties, Current $23.69M.
| Period end | Accrued Royalties, Current |
|---|---|
| 2025-09-30 | $27.49M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $23.85M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $24.51M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $23.69M 10-Q · filed 2025-11-06 |
| 2024-09-30 | $26.10M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $26.32M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $19.78M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $23.34M 10-Q · filed 2024-11-12 |
| 2023-09-30 | $27.06M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $27.17M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $17.37M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $19.31M 10-Q · filed 2023-11-09 |
| 2021-12-31 | $20.89M 10-K · filed 2023-03-03 |
| 2020-12-31 | $21.78M 10-K · filed 2022-03-01 |
| 2019-12-31 | $28.97M 10-K · filed 2021-03-01 |
| 2018-12-31 | $23.64M 10-K · filed 2020-03-02 |
| 2018-09-30 | $19.63M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $20.63M 10-Q · filed 2018-08-09 |
| 2017-12-31 | $2.97M 10-K · filed 2019-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |